{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:22:25Z","timestamp":1765545745253},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T00:00:00Z","timestamp":1334793600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2012.38","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T10:13:20Z","timestamp":1334830400000},"page":"e299-e299","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin\u2013NFAT pathway"],"prefix":"10.1038","volume":"3","author":[{"given":"P E","family":"Cipp\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Lindenmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Guimezanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P D","family":"Bardwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Wekerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R P","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,19]]},"reference":[{"key":"BFcddis201238_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/cdd.2008.137","volume":"16","author":"M Vogler","year":"2009","unstructured":"Vogler M, Dinsdale D, Dyer MJ, Cohen GM . Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 2009; 16: 360\u2013367.","journal-title":"Cell Death Differ"},{"key":"BFcddis201238_CR2","doi-asserted-by":"publisher","first-page":"10967","DOI":"10.1073\/pnas.1005256107","volume":"107","author":"EM Carrington","year":"2010","unstructured":"Carrington EM, Vikstrom IB, Light A, Sutherland RB, Londrigan SL, Mason KD et al. BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci USA. 2010; 107: 10967\u201310971.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BFcddis201238_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nature03579","volume":"435","author":"T Oltersdorf","year":"2005","unstructured":"Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435: 677\u2013681.","journal-title":"Nature"},{"key":"BFcddis201238_CR4","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","volume":"68","author":"C Tse","year":"2008","unstructured":"Tse C, Shoemaker AR, Adickes J, Chen J, Jin S, Johnson EF et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 2008; 68: 3421\u20133428.","journal-title":"Cancer Res"},{"key":"BFcddis201238_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","volume":"11","author":"WH Wilson","year":"2010","unstructured":"Wilson WH, O\u2019Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol 2010; 11: 1149\u20131159.","journal-title":"Lancet Oncol"},{"key":"BFcddis201238_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1182\/blood-2007-06-098012","volume":"111","author":"V Del Gaizo Moore","year":"2008","unstructured":"Del Gaizo Moore V, Schlis KD, Sallan SE, Armstrong SA, Letai A . BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia. Blood 2008; 111: 2300\u20132309.","journal-title":"Blood"},{"key":"BFcddis201238_CR7","doi-asserted-by":"crossref","unstructured":"Yecies D, Carlson NE, Deng J, Letai A . Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood 115: 3304\u20133313.","DOI":"10.1182\/blood-2009-07-233304"},{"key":"BFcddis201238_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev.immunol.21.120601.141029","volume":"21","author":"VS Marsden","year":"2003","unstructured":"Marsden VS, Strasser A . Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol 2003; 21: 71\u2013105.","journal-title":"Annu Rev Immunol"},{"key":"BFcddis201238_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2009.11.014","volume":"32","author":"JH Cho","year":"2010","unstructured":"Cho JH, Kim HO, Surh CD, Sprent J . T cell receptor-dependent regulation of lipid rafts controls naive CD8+ T cell homeostasis. Immunity 2010; 32: 214\u2013226.","journal-title":"Immunity"},{"key":"BFcddis201238_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.immuni.2007.12.017","volume":"28","author":"PD Hughes","year":"2008","unstructured":"Hughes PD, Belz GT, Fortner KA, Budd RC, Strasser A, Bouillet P . Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 2008; 28: 197\u2013205.","journal-title":"Immunity"},{"key":"BFcddis201238_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nri2570","volume":"9","author":"P Bouillet","year":"2009","unstructured":"Bouillet P, O'Reilly LA . CD95, BIM and T cell homeostasis. Nat Rev Immunol 2009; 9: 514\u2013519.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis201238_CR12","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1073\/pnas.0706913105","volume":"105","author":"SF Fischer","year":"2008","unstructured":"Fischer SF, Belz GT, Strasser A . BH3-only protein Puma contributes to death of antigen-specific T cells during shutdown of an immune response to acute viral infection. Proc Natl Acad Sci USA. 2008; 105: 3035\u20133040.","journal-title":"Proc Natl Acad Sci USA."},{"key":"BFcddis201238_CR13","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.4049\/jimmunol.180.12.8093","volume":"180","author":"L Sabbagh","year":"2008","unstructured":"Sabbagh L, Pulle G, Liu Y, Tsitsikov EN, Watts TH . ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. J Immunol 2008; 180: 8093\u20138101.","journal-title":"J Immunol"},{"key":"BFcddis201238_CR14","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1084\/jem.20070618","volume":"204","author":"S Wojciechowski","year":"2007","unstructured":"Wojciechowski S, Tripathi P, Bourdeau T, Acero L, Grimes HL, Katz JD et al. Bim\/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med 2007; 204: 1665\u20131675.","journal-title":"J Exp Med"},{"key":"BFcddis201238_CR15","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1182\/blood-2009-07-230680","volume":"115","author":"T Fehr","year":"2010","unstructured":"Fehr T, Lucas CL, Kurtz J, Onoe T, Zhao G, Hogan T et al. A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo. Blood 2010; 115: 1280\u20131287.","journal-title":"Blood"},{"key":"BFcddis201238_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/sj.cdd.4401265","volume":"10","author":"C Verschelde","year":"2003","unstructured":"Verschelde C, Walzer T, Galia P, Biemont MC, Quemeneur L, Revillard JP et al. A1\/Bfl-1 expression is restricted to TCR engagement in T lymphocytes. Cell Death Differ 2003; 10: 1059\u20131067.","journal-title":"Cell Death Differ"},{"key":"BFcddis201238_CR17","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1182\/blood-2002-04-1229","volume":"101","author":"J Gonzalez","year":"2003","unstructured":"Gonzalez J, Orlofsky A, Prystowsky MB . A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells. Blood 2003; 101: 2679\u20132685.","journal-title":"Blood"},{"key":"BFcddis201238_CR18","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.4049\/jimmunol.0802813","volume":"182","author":"PD Bardwell","year":"2009","unstructured":"Bardwell PD, Gu J, McCarthy D, Wallace C, Bryant S, Goess C et al. The Bcl-2 family antagonist ABT-737 significantly inhibits multiple animal models of autoimmunity. J Immunol 2009; 182: 7482\u20137489.","journal-title":"J Immunol"},{"key":"BFcddis201238_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1432-2277.2011.01272.x","volume":"24","author":"PE Cippa","year":"2011","unstructured":"Cippa PE, Kraus AK, Edenhofer I, Segerer S, Chen J, Hausmann M et al. The BH3-mimetic ABT-737 inhibits allogeneic immune responses. Transpl Int 2011; 24: 722\u2013732.","journal-title":"Transpl Int"},{"key":"BFcddis201238_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1189\/jlb.0311174","volume":"90","author":"KE Lawlor","year":"2011","unstructured":"Lawlor KE, Smith SD, van Nieuwenhuijze A, Huang DC, Wicks IP . Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritis. J Leukoc Biol 2011; 90: 819\u2013829.","journal-title":"J Leukoc Biol"},{"key":"BFcddis201238_CR21","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1182\/blood-2011-03-340364","volume":"118","author":"S Al-Harbi","year":"2011","unstructured":"Al-Harbi S, Hill BT, Mazumder S, Singh K, Devecchio J, Choudhary G et al. An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood 2011; 118: 3579\u20133590.","journal-title":"Blood"},{"key":"BFcddis201238_CR22","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1084\/jem.188.11.1985","volume":"188","author":"A Hamasaki","year":"1998","unstructured":"Hamasaki A, Sendo F, Nakayama K, Ishida N, Negishi I, Hatakeyama S . Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 1998; 188: 1985\u20131992.","journal-title":"J Exp Med"},{"key":"BFcddis201238_CR23","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1016\/j.bmcl.2010.09.046","volume":"20","author":"JR Cashman","year":"2010","unstructured":"Cashman JR, MacDonald M, Ghirmai S, Okolowicz KJ, Sergienko E, Brown B et al. Inhibition of Bfl-1 with N-aryl maleimides. Bioorg Med Chem Lett 2010; 20: 6560\u20136564.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFcddis201238_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nri2940","volume":"11","author":"P Matzinger","year":"2011","unstructured":"Matzinger P, Kamala T . Tissue-based class control: the other side of tolerance. Nat Rev Immunol 2011; 11: 221\u2013230.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis201238_CR25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1126\/science.285.5436.2129","volume":"285","author":"J Aramburu","year":"1999","unstructured":"Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A . Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999; 285: 2129\u20132133.","journal-title":"Science"},{"key":"BFcddis201238_CR26","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","volume":"113","author":"M Vogler","year":"2009","unstructured":"Vogler M, Butterworth M, Majid A, Walewska RJ, Sun XM, Dyer MJ et al. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood 2009; 113: 4403\u20134413.","journal-title":"Blood"},{"key":"BFcddis201238_CR27","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1182\/blood-2006-10-053371","volume":"111","author":"E Ulleras","year":"2008","unstructured":"Ulleras E, Karlberg M, Moller Westerberg C, Alfredsson J, Gerondakis S, Strasser A et al. NFAT but not NF-kappaB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells. Blood 2008; 111: 3081\u20133089.","journal-title":"Blood"},{"key":"BFcddis201238_CR28","doi-asserted-by":"crossref","unstructured":"Wensveen FM, van Gisbergen KP, Derks IA, Gerlach C, Schumacher TN, van Lier RA et al. Apoptosis threshold set by Noxa and Mcl-1 after T cell activation regulates competitive selection of high-affinity clones. Immunity 32: 754\u2013765.","DOI":"10.1016\/j.immuni.2010.06.005"},{"key":"BFcddis201238_CR29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1056\/NEJMra0901217","volume":"361","author":"RS Hotchkiss","year":"2009","unstructured":"Hotchkiss RS, Strasser A, McDunn JE, Swanson PE . Cell death. N Engl J Med. 2009; 361: 1570\u20131583.","journal-title":"N Engl J Med."},{"key":"BFcddis201238_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-5793(96)00280-3","volume":"384","author":"N Zamzami","year":"1996","unstructured":"Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse B et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996; 384: 53\u201357.","journal-title":"FEBS Lett"},{"key":"BFcddis201238_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri2818","volume":"10","author":"MR Muller","year":"2010","unstructured":"Muller MR, A. Rao . NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 2010; 10: 645\u2013656.","journal-title":"Nat Rev Immunol"},{"key":"BFcddis201238_CR32","doi-asserted-by":"publisher","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","volume":"3","author":"P Sagoo","year":"2011","unstructured":"Sagoo P, Ali N, Garg G, Nestle FO, Lechler RI, Lombardi G . Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med 2011; 3: 83ra42.","journal-title":"Sci Transl Med"},{"key":"BFcddis201238_CR33","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/eji.1830240718","volume":"24","author":"N Auphan","year":"1994","unstructured":"Auphan N, Curnow J, Guimezanes A, Langlet C, Malissen B, Mellor A et al. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the T cell receptor (TCR) and influences negative selection in TCR-transgenic mice. Eur J Immunol 1994; 24: 1572\u20131577.","journal-title":"Eur J Immunol"},{"key":"BFcddis201238_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4","volume":"31","author":"A Guimezanes","year":"2001","unstructured":"Guimezanes A, Barrett-Wilt GA, Gulden-Thompson P, Shabanowitz J, Engelhard VH, Hunt DF et al. Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 dependence. Eur J Immunol 2001; 31: 421\u2013432.","journal-title":"Eur J Immunol"},{"key":"BFcddis201238_CR35","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1182\/blood-2007-12-127449","volume":"112","author":"F Haspot","year":"2008","unstructured":"Haspot F, Fehr T, Gibbons C, Zhao G, Hogan T, Honjo T et al. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1\/PD-L1 pathway. Blood 2008; 112: 2149\u20132155.","journal-title":"Blood"},{"key":"BFcddis201238_CR36","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/eji.200526190","volume":"35","author":"T Fehr","year":"2005","unstructured":"Fehr T, Takeuchi Y, Kurtz J, Wekerle T, Sykes M . Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation. Eur J Immunol 2005; 35: 2679\u20132690.","journal-title":"Eur J Immunol"},{"key":"BFcddis201238_CR37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.4049\/jimmunol.148.3.657","volume":"148","author":"M Buferne","year":"1992","unstructured":"Buferne M, Luton F, Letourneur F, Hoeveler A, Couez D, Barad M et al. Role of CD3 delta in surface expression of the TCR\/CD3 complex and in activation for killing analyzed with a CD3 delta-negative cytotoxic T lymphocyte variant. J Immunol 1992; 148: 657\u2013664.","journal-title":"J Immunol"},{"key":"BFcddis201238_CR38","doi-asserted-by":"publisher","first-page":"e11545","DOI":"10.1371\/journal.pone.0011545","volume":"5","author":"MT Lindenmeyer","year":"2010","unstructured":"Lindenmeyer MT, Eichinger F, Sen K, Anders HJ, Edenhofer I, Mattinzoli D et al. Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset. PLoS One 2010; 5: e11545.","journal-title":"PLoS One"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cddis201238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cddis201238","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:49:51Z","timestamp":1672962591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,19]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["BFcddis201238"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2012.38","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,19]]},"assertion":[{"value":"1 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PDB is an employee of Abbott, which developed and provided ABT-737. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}